ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Ophthalmology

Top Ophthalmology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NGOC NGUYEN M.D.

Ophthalmology

20,255

$2.32M

2298
2212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

81%
prescriptions for brand name drugs

Avg: 58%

$115
Average prescription price

Avg: $80

CUONG-DUNG DO M.D.

Ophthalmology

17,647

$1.61M

1869
1734 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 58%

$91
Average prescription price

Avg: $80

ANDREW CHO M.D.

Ophthalmology

16,988

$1.92M

2379
2288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

79%
prescriptions for brand name drugs

Avg: 58%

$113
Average prescription price

Avg: $80

TIN-CHEU WONG M.D.

Ophthalmology

15,786

$2.44M

1577
1530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 58%

$155
Average prescription price

Avg: $80

SHIU KWOK MD

Ophthalmology

15,479

$1.42M

2397
2315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 58%

$92
Average prescription price

Avg: $80

TRIET NGUYEN M.D.

Ophthalmology

13,738

$2.5M

726
653 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

96%
prescriptions for brand name drugs

Avg: 58%

$182
Average prescription price

Avg: $80

BRIAN CAVALLARO M.D.

Ophthalmology

13,608

$943K

1699
1570 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 58%

$69
Average prescription price

Avg: $80

MICHAEL ROSE MD

Ophthalmology

12,631

$1.77M

1230
1091 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

86%
prescriptions for brand name drugs

Avg: 58%

$140
Average prescription price

Avg: $80

TUYET-MAI PHAN M.D.

Ophthalmology

12,386

$1.11M

1365
1316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 58%

$89
Average prescription price

Avg: $80

RICHARD HAVUNJIAN M.D.

Ophthalmology

12,200

$1.6M

1496
1400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 58%

$131
Average prescription price

Avg: $80

GARLAN LO M.D.

Ophthalmology

11,540

$1.22M

1918
1867 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 58%

$106
Average prescription price

Avg: $80

NAZARETH DARAKJIAN M.D.

Ophthalmology

11,268

$907K

1523
1420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 58%

$81
Average prescription price

Avg: $80

ARTHUR LU MD

Ophthalmology

11,046

$1.43M

1116
1049 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

84%
prescriptions for brand name drugs

Avg: 58%

$130
Average prescription price

Avg: $80

YUN KIM MD

Ophthalmology

10,222

$1.25M

1103
1076 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

82%
prescriptions for brand name drugs

Avg: 58%

$123
Average prescription price

Avg: $80

ALEJANDRA UCHIO M.D.

Ophthalmology

10,105

$964K

1780
1582 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

75%
prescriptions for brand name drugs

Avg: 58%

$95
Average prescription price

Avg: $80

SOK NAM M.D.

Ophthalmology

9,492

$1.58M

1850
1744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

93%
prescriptions for brand name drugs

Avg: 58%

$166
Average prescription price

Avg: $80

JESSE DOVICH M.D.

Ophthalmology

9,383

$578K

1786
1612 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 58%

$62
Average prescription price

Avg: $80

SUNMIN PARK M.D.

Ophthalmology

9,154

$1.5M

921
885 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

86%
prescriptions for brand name drugs

Avg: 58%

$164
Average prescription price

Avg: $80

MATTHEW BERNSTEIN MD

Ophthalmology

9,145

$975K

1124
842 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 58%

$107
Average prescription price

Avg: $80

MAJID MANI M.D.

Ophthalmology

9,144

$739K

2075
1695 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 58%

$81
Average prescription price

Avg: $80

HAMID MANI M.D.

Ophthalmology

9,016

$783K

1376
1157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 58%

$87
Average prescription price

Avg: $80

RON GALLEMORE MD

Ophthalmology

8,730

$772K

1352
1157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 58%

$88
Average prescription price

Avg: $80

NASRIN MANI M.D.

Ophthalmology

8,696

$703K

1632
1342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 58%

$81
Average prescription price

Avg: $80

ARTHUR BENJAMIN M. D.

Ophthalmology

8,311

$903K

848
795 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 58%

$109
Average prescription price

Avg: $80

CALVIN ENG M.D.

Ophthalmology

8,253

$602K

1531
1466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 58%

$73
Average prescription price

Avg: $80

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank